简介：
Overview
This protocol provides a systematic framework for establishing ovarian cancer organoids from various disease stages, addressing patient-specific variability to enhance yield and enable robust long-term expansion. It includes detailed steps for tissue processing, seeding, media adjustments, and immunofluorescence staining.
Key Study Components
Area of Science
- Ovarian cancer research
- Organoid technology
- Translational medicine
Background
- Patient-derived organoids are crucial for personalized cancer treatment.
- Advancements in surgery and therapies have improved survival rates.
- Current treatment decisions rely on general histopathological features.
- Identifying predictive biomarkers is essential for tailored therapies.
Purpose of Study
- To establish a reliable method for creating ovarian cancer organoids.
- To address challenges related to patient-specific variability.
- To enable long-term expansion of organoids for research and treatment applications.
Methods Used
- Tissue processing techniques for organoid establishment.
- Seeding protocols for optimal growth.
- Media adjustments to support organoid viability.
- Immunofluorescence staining for characterization.
Main Results
- Successful establishment of organoids from different ovarian cancer stages.
- Enhanced understanding of patient-specific characteristics.
- Improved methods for long-term organoid culture.
- Potential for identifying biomarkers for treatment response.
Conclusions
- The protocol facilitates the creation of patient-specific ovarian cancer organoids.
- It addresses variability and enhances the potential for personalized treatment.
- Future research can leverage these organoids for predictive biomarker discovery.
What are ovarian cancer organoids?
Ovarian cancer organoids are 3D cell cultures derived from patient tumors that mimic the disease's characteristics.
How do organoids help in cancer research?
Organoids allow researchers to study tumor behavior and test treatments in a patient-specific context.
What challenges does this protocol address?
It addresses patient-specific variability and aims to improve the yield and expansion of organoids.
What methods are used in this protocol?
The protocol includes tissue processing, seeding, media adjustments, and immunofluorescence staining.
Why is long-term expansion of organoids important?
Long-term expansion allows for extensive research and testing of therapies over time.
What is the significance of predictive biomarkers?
Predictive biomarkers help identify which patients will benefit from specific treatments, enhancing personalized medicine.
繁體中文
